Zydus Cadila Covid vaccine gets DCGI nod for human clinical
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
After Bharat Biotech's Covaxin, another potential COVID-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila, ZyCoV-D, got the nod from the Drugs Controller General of India (DCGI) on Thursday (2 July) for human clinical trials, government sources said.

The approval process was fast-tracked following a recommendation by the subject expert committee on COVID-19, considering the emergency and unmet medical need during the pandemic.

The assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the vaccine candidate was found to be successful with respect to safety and immunogenicity, sources said.

The company is likely to start enrolment of subjects soon.

"The phase I and II trials will take around three months to be completed," the source said.

Source: https://www.indiatoday.in/india/story/zydus-cadila-covid-vaccine-gets-dcgi-nod-for-human-clinical-trials-1696456-2020-07-03
Dr. T●●●●z H●●●●●●i and 13 others like this8 shares
Like
Comment
Share